Phenylketone carboxylate compounds of Formula I, wherein n=2-6; R=C(0); -OC(O)- or -CH( OH)-; A is (CH2)mCOOH, W(CH2)mCOOH or YCH(COOH)((CH2)pCH3) when B is Ft B is (CH2)mCOOH, W(CH2)mCOOH or YCH(COOH)((CH2)pCH3) when A is Ft or A snd B form a 5-7 membered cycloalkyl substituted with COOFt W=0, S or NFt Y=0,S,NH or CH2; m=0-2; p=l-7; have been prepared. These compounds and their pharmaceutically acceptable salts have beneficial therapeutic effects to prevent or treat a condition related to (l) blood disorders, (ii) inflammation related diseases, (iii) renal disorders and/or renal disorders complications, or (iv) fibrosis-related organ dysfunction.
Phenylketone
羧酸酯化合物的
化学式I,其中n=2-6;R=C(0); -OC(O)-或-CH( OH)-;A是(
CH2)mCOOH,W( )mCOOH或YCH(COOH)(( )pCH3),当B是Ft时B是( )mCOOH,W( )mCOOH或YCH(COOH)(( )pCH3),当A是Ft时或A和B形成一个含有COOFt的5-7元环烷基取代物。W=0,S或NFt;Y=0,S,NH或 ;m=0-2;p=1-7;已经制备。这些化合物及其药学上可接受的盐对预防或治疗与(l)血液疾病有关的情况,(ii)炎症相关疾病,(iii)肾功能紊乱和/或肾功能紊乱并发症,或(iv)纤维化相关器官功能障碍具有有益的治疗效果。